Abstracts tagged "Lupus and community programs"

Abstract Number: 281 • 2018 ACR/ARHP Annual Meeting
Development of an African American Lupus Community-Based Patient and Provider Education Program: Lupus Conversations
Karen Mancera-Cuevas¹, Courtnie Phillip², Cianna Leatherwood³, Chase Correia⁴, James Brucker⁴, Elmer Freeman⁵, Gail Granville⁶, Kay Mimms⁷, Patricia Canessa⁸, Candace H. Feldman³ and Rosalind Ramsey-Goldman⁹, ¹Rheumatology, Northwestern University, Chicago, IL, ²Brigham and Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Northwestern University, Chicago, IL, ⁵Northeastern University, Boston, MA, ⁶Women of Courage, Inc., Boston, MA, ⁷Lupus Society of Illinois, Chicago, IL, ⁸Illinois Public Health Association, Springfield, IL, ⁹FSM, Northwestern University, Chicago, IL
Background/Purpose: African Americans (AA) with lupus experience severe manifestations and outcomes, and a long journey to diagnosis and care. We developed and tested evidence-based, culturally…
Abstract Number: 1842 • 2018 ACR/ARHP Annual Meeting
Implementation of an African American Popular Opinion Leader Model to Address Disparities in Lupus Knowledge and Care
Courtnie Phillip¹, Cianna Leatherwood², Elmer Freeman³, Gail Granville⁴, Gayna Sealy⁵, Toni Wiley⁵, Chase Correia⁶, Karen Mancera-Cuevas⁷, Patricia Canessa⁸, Rosalind Ramsey-Goldman⁹ and Candace H. Feldman², ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Northeastern University, Boston, MA, ⁴Women of Courage, Inc., Boston, MA, ⁵Sportsmen's Tennis and Enrichment Center, Dorchester, MA, ⁶Northwestern University, Chicago, IL, ⁷Rheumatology, Northwestern University, Chicago, IL, ⁸Illinois Public Health Association, Springfield, IL, ⁹FSM, Northwestern University, Chicago, IL
Background/Purpose: Lupus is a chronic, autoimmune disease that disproportionately affects African American individuals. Community-based educational interventions that capitalize on rich social networks can be used…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].